Irritable Bowel Syndrome

In this episode, Douglas A. Drossman, MD, joins us to discuss his path into medicine, the history and influence of brain-gut interactions and what gastroenterologists can expect for Rome V criteria.

The American College of Gastroenterology developed clinical guidelines for the treatment of irritable bowel syndrome.

Parallel, a prescription digital therapeutic developed by Mahana Therapeutics for the treatment of irritable bowel syndrome, received marketing authorization from the FDA, according to a company press release.

During this year’s ACG 2020 Virtual meeting, Healio will host its annual Disruptive Innovators Award ceremony at 7:30 P.M. on Monday, October 26.

In a composite of three trials, rifaximin provided a durable and significant improvement in bloating in patients with diarrhea-predominant irritable bowel syndrome as compared with placebo, according to results presented at UEG Week.

Allergy-related diseases, including asthma and food hypersensitivity, in childhood were associated with an increased risk of having irritable bowel syndrome at age 16 years, according to research presented at UEG Week Virtual.

Cedars-Sinai recently launched a breath test to help diagnose small intestine bacterial overgrowth related to irritable bowel syndrome. It was the top story in gastroenterology last week.

Some complimentary alternative therapies, including herbal and dietary supplements, may help ease abdominal pain and benefit overall response in patients with irritable bowel syndrome, according to study results.

In this episode, Peter Gibson, MD, discusses the advent of FODMAPs, the importance of integrated care and preventive medicine, and how his research led to the development of a widely popular medical app.

Children with celiac disease have a higher risk for irritable bowel syndrome and functional constipation even if they adhere to a gluten-free diet, according to study results.